[KongchangAI]
Unverified75% confidenceDecision RuleTime unknown

淫羊藿苷(icariin)口服吸收率低,经酶解或发酵工艺转化为宝藿苷I(baohuoside I)或淫羊藿次苷II后生物利用度显著提升,优先选择标注'酶解/生物转化'工艺的产品

1
Sources
75%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/451443
API
curl https://kongchang.com/api/v1/knowledge/claims/451443
MCP
get_claim(id=451443)